We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$84.5B
AUM Growth
-$745M
Cap. Flow
+$13.7B
Cap. Flow %
16.26%
Top 10 Hldgs %
10.97%
Holding
4,738
New
695
Increased
1,955
Reduced
1,481
Closed
562

Sector Composition

Rank Sector Weight
1 Healthcare 19.41%
2 Technology 16.8%
3 Consumer Staples 11.12%
4 Consumer Discretionary 10.11%
5 Financials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WVVI icon
2876
Willamette Valley Vineyards
WVVI
$12.7M
$774K ﹤0.01%
123,452
-17,905
-13% -$137K
RNAC icon
2877
Cartesian Therapeutics
RNAC
$231M
$771K ﹤0.01%
19,613
-30,067
-61% -$891K
ETTX
2878
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$771K ﹤0.01%
350,345
+26,500
+8% +$52.9K
STRO icon
2879
Sutro Biopharma
STRO
$416M
$770K ﹤0.01%
+14,770
New +$825K
AQB icon
2880
AquaBounty Technologies
AQB
$4.73M
$769K ﹤0.01%
22,480
-9,856
-30% -$301K
DFAU icon
2881
Dimensional US Core Equity Market ETF
DFAU
$12.6B
$769K ﹤0.01%
+29,100
New +$835K
GCO icon
2882
Genesco
GCO
$435M
$769K ﹤0.01%
+15,400
New +$923K
MCRI icon
2883
Monarch Casino & Resort
MCRI
$2.24B
$769K ﹤0.01%
13,100
+7,900
+152% +$554K
ERAS icon
2884
Erasca
ERAS
$6.19B
$767K ﹤0.01%
137,700
+116,500
+550% +$763K
VVNT
2885
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
$767K ﹤0.01%
220,426
-47,374
-18% -$252K
ALJJ
2886
DELISTED
ALJ Regional Holdings Inc
ALJJ
$767K ﹤0.01%
397,471
+33,400
+9% +$74.5K
BNFT
2887
DELISTED
Benefitfocus, Inc.
BNFT
$766K ﹤0.01%
98,500
+19,000
+24% +$188K
CGNT icon
2888
Cognyte Software
CGNT
$676M
$765K ﹤0.01%
180,100
+121,400
+207% +$851K
SPEM icon
2889
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.3B
$761K ﹤0.01%
+21,900
New +$791K
BILI icon
2890
Bilibili
BILI
$8.05B
$760K ﹤0.01%
29,700
-37,100
-56% -$892K
EWL icon
2891
iShares MSCI Switzerland ETF
EWL
$2.19B
$760K ﹤0.01%
+18,300
New +$822K
MRNS
2892
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$759K ﹤0.01%
156,900
+123,000
+363% +$748K
ARVN icon
2893
Arvinas
ARVN
$520M
$758K ﹤0.01%
18,000
-112,400
-86% -$5.64M
CBNK icon
2894
Capital Bancorp
CBNK
$613M
$757K ﹤0.01%
34,900
-27,500
-44% -$613K
AHT
2895
Ashford Hospitality Trust
AHT
$21M
$753K ﹤0.01%
12,591
-23,050
-65% -$1.55M
NSSC icon
2896
Napco Security Technologies
NSSC
$1.36B
$752K ﹤0.01%
36,500
+23,000
+170% +$433K
SPHQ icon
2897
Invesco S&P 500 Quality ETF
SPHQ
$19.6B
$752K ﹤0.01%
17,900
-3,200
-15% -$147K
NOBL icon
2898
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.8B
$751K ﹤0.01%
17,600
-25,200
-59% -$1.15M
VOC icon
2899
VOC Energy
VOC
$50.8M
$750K ﹤0.01%
115,600
-86,183
-43% -$637K
GLDG
2900
GoldMining Inc
GLDG
$190M
$748K ﹤0.01%
791,700
+81,225
+11% +$104K

Similar funds

Renaissance Technologies's Q2 2022 Portfolio in Review

As of Q2 2022, Renaissance Technologies held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Renaissance Technologies deployed $13.7B of net new capital in Q2 2022, opening 695 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.

  • Renaissance Technologies's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
  • Renaissance Technologies added most to Chevron in Q2 2022, an estimated $820M increase.
  • Renaissance Technologies's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
  • Renaissance Technologies fully exited Amazon in Q2 2022, selling an estimated $675M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
  • Renaissance Technologies opened 695 new positions and closed 562 in Q2 2022.
  • Renaissance Technologies's portfolio value fell 0.87% quarter-over-quarter to $84.5B.

Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.